Hasselbalch Hans Carl

50PUBLICATIONS
123CO-AUTHORS
Predictive and prognostic markersHaematological tumoursRegenerative medicine (incl. stem cells)Gene and molecular therapyCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (50)

|Sep 01, 2026
High Prevalence of the JAK2V617F Mutation in Patients With Acute Coronary Syndrome.

|Aug 13, 2026
Collagen Turnover Is Associated with Disease Severity, Bone Marrow Fibrosis, and the JAK2V617F Variant Allele Frequency in Myeloproliferative Neoplasms.

|Apr 08, 2026
A paradigm shift in the treatment of patients with polycythemia vera. The initial early use of recombinant interferon-alpha.

Richard T Silver, Hans Carl Hasselbalch

|Feb 26, 2026
Prime time for the use of statins in MPNs: from comorbidity drugs to disease-modifying partners.

Hans Carl Hasselbalch

|Dec 23, 2025
Atrial Fibrillation in Philadelphia Chromosome-negative Myeloproliferative Neoplasms: Thromboinflammatory Crosstalk with a Focus on the NLRP3 Inflammasome.

Olga Demska, Marta Szandruk-Bender, Niels Eske Bruun

|Sep 18, 2025
Statins enhance the efficacy of pegylated interferon-alfa2 in Philadelphia-negative chronic myeloproliferative neoplasms.

Isabella Diana Davidsen, Morten Kranker Larsen, Lea Löffler

Pageof 9

Frequent Collaborators

31 joint publications

Vibe Skov

21 joint publications

Lasse Kjaer

15 joint publications

Ellervik Christina

15 joint publications

Morten Kranker Larsen